glp 1 agonist risks Gastrointestinal effect and adverse effects of GLP-1 receptor Glucagon-like peptide-1 receptor agonists and

Chan M, Dimitriou A, Lam S

Synthetic forms of glucagon are available for treatment of severe acute hypoglycemia, including the intramuscular Gvoke HypoPen and a nasal powder called Baqsimi [BAK see mee]come back to see me

These include people who have type 1 diabetes or have had ketoacidosis in the past

Rising disposable incomes, growing recognition of diabetes-related risks, and government efforts to enhance chronic disease management are expected to support substantial market growth for GLP-1 receptor agonists across Asia Pacific

doi: 10.1111/dom.13985 [DOI] [PMC free article] [PubMed] [Google Scholar] 193.Geiser JS, Heathman MA, Cui X, et al

Saini, S